Publications:

Investigation of PALB2 Mutation and Correlation With Immunotherapy Biomarker in Chinese Non-Small Cell Lung Cancer Patients.

Frontiers In Oncology

Zhang, Jiexia J; Tang, Shuangfeng S; Zhang, Chunning C; Li, Mingyao M; Zheng, Yating Y; Hu, Xue X; Huang, Mengli M; Cheng, Xiangyang X

Publication Date: 2021

Variant appearance in text: IGF1R: 128A>G; Y43C

PubMed Link: 35087742

Variant Present in the following documents:

• Table_1.xlsx, sheet 1
• Table_2.xlsx, sheet 1

View BVdb publication page

Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.

Nature

Yao, Zhan Z; Yaeger, Rona R; Rodrik-Outmezguine, Vanessa S VS; Tao, Anthony A; Torres, Neilawattie M NM; Chang, Matthew T MT; Drosten, Matthias M; Zhao, Huiyong H; Cecchi, Fabiola F; Hembrough, Todd T; Michels, Judith J; Baumert, Hervé H; Miles, Linde L; Campbell, Naomi M NM; de Stanchina, Elisa E; Solit, David B DB; Barbacid, Mariano M; Taylor, Barry S BS; Rosen, Neal N

Publication Date: 2017-08-10

Variant appearance in text: IGF1R: 128A>G; Y43C

PubMed Link: 28783719

Variant Present in the following documents:

• Main text

View BVdb publication page

Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus.

Oncotarget

Lim, Sun Min SM; Park, Hyung Soon HS; Kim, Sangwoo S; Kim, Sora S; Ali, Siraj M SM; Greenbowe, Joel R JR; Yang, In Seok IS; Kwon, Nak-Jung NJ; Lee, Jae Lyun JL; Ryu, Min-Hee MH; Ahn, Jin-Hee JH; Lee, Jeeyun J; Lee, Min Goo MG; Kim, Hyo Song HS; Kim, Hyunki H; Kim, Hye Ryun HR; Moon, Yong Wha YW; Chung, Hyun Cheol HC; Kim, Joo-Hang JH; Kang, Yoon-Koo YK; Cho, Byoung Chul BC

Publication Date: 2016-03-01

Variant appearance in text: IGF1R: Y43C

PubMed Link: 26859683

Variant Present in the following documents:

• oncotarget-07-10547-s002.pdf

View BVdb publication page